(Q45269971)

11 December 2017

1 reference

title

Treatment of human enterovirus infections (English)

1 reference

11 December 2017

H. A. Rotbart

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9613999

25 December 2024

J. F. O'Connell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9613999

25 December 2024

M. A. McKinlay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9613999

25 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9613999

25 December 2024

publication date

1 April 1998

1 reference

11 December 2017

April 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9613999

full work available at URL

25 December 2024

https://api.elsevier.com/content/article/PII:S0166354297000685?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0166-3542(97)00068-5

https://api.elsevier.com/content/article/PII:S0166354297000685?httpAccept=text/plain

25 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0166-3542(97)00068-5

25 December 2024

1 reference

11 December 2017

volume

38

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

1-14

1 reference

Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Age dependence of paralysis induced by echovirus type 9 in infant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

SCH 48973: a potent, broad-spectrum, antienterovirus compound

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Role of Interferon in Lethality and Lymphoid Atrophy Induced by Coxsackievirus B3 Infection of Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Nonpolio enteroviruses and the febrile young infant: epidemiologic, clinical and diagnostic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

A combination of four cell types for rapid detection of enteroviruses in clinical specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Rhodanine: a selective inhibitor of the multiplication of echovirus 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Role of interferon, antibodies and macrophages in the protective effect of Corynebacterium parvum on encephalomyocarditis virus-induced disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Prophylactic Effect of Low Doses of Human Leukocyte Interferon Against Infection with Rhinovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Intranasal Interferon 2 for Prevention of Rhinovirus Infection and Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Three-dimensional structure of poliovirus at 2.9 A resolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Neutralizing antibody and interferon-alpha in cerebrospinal fluids and sera of acute aseptic meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Antipicornavirus flavone Ro 09-0179

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Antipicornavirus activity of some diaryl methanes and aralkylaminopyridines

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Activity of arildone with or without interferon against acute hemorrhagic conjunctivitis viruses in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Method for detection of picornavirus capsid binders with soluble intercellular adhesion molecule 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Role of soluble cytokines on the restricted replication of poliovirus in the monocytic U937 cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Oral efficacy of WIN 51711 in mice infected with human poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Chronic enteroviral meningoencephalitis in agammaglobulinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Pathogenesis of coxsackie virus infection; multiplication of virus and evolution of the muscle lesion in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Infectivity liters of enterovirus as found in human stools

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

1 reference

7 January 2021

Controlled trial of enviroxime against natural rhinovirus infections in a community

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Perinatal echovirus infection: risk of transmission during a community outbreak.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Enterovirus infection of the central nervous system of humans: lack of association with chronic neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

The activity of enviroxime against rhinovirus infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Therapeutic activity of enviroxime against rhinovirus infection in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Virus-Induced Interferon Production in Human Leukocytes: A Low Responder to One Virus Can Be a High Responder to Another Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Comparison of arildone and 3-methylquercetin as stabilizers of poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Use of intravenous immunoglobulin in twin neonates with disseminated coxsackie B1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Diagnosis of enterovirus brain disease in hypogammaglobulinemic patients by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900068-5

7 January 2021

Late Postpoliomyelitis Muscular Atrophy: Clinical, Virologic, and Immunologic Studies

20

1 reference

https://api.crossref.org/works/10.1016/S0166-3542(97)00068-5

Inhibition of respiratory virus infection by locally applied interferon

25 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/S0166-3542(97)00068-5

Combination treatment with ribavirin and interferon for coxsackievirus B3 replication

25 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/S0166-3542(97)00068-5

Oral bioavailability screening of the antirhinoviral vinyl acetylene benzimidazoles

25 December 2024

95

1 reference

https://api.crossref.org/works/10.1016/S0166-3542(97)00068-5

25 December 2024

Identifiers

1 reference

11 December 2017

1 reference